Dr. Reddy's Successfully Completes Phase I Study (IV Route)

Tocilizumab is an important anti-rheumatic agent used in the treatment of adult patients with moderate to severe active rheumatoid arthritis who have had an inadequate response to one or more... | June 5, 2023

Related Keywords

United States , Hyderabad , Andhra Pradesh , India , Brazil , China , Russia , Reddy Tocilizumab , Jayanth Sridhar , Tocilizumab Roactemra , Tocilizumab Actemra , Reddy Laboratories Ltd , Exchange Commission , Chugai Seiyaku Kabushiki Kaisha Corp , Good Health Cant Wait , Roche Group , Double Blind , Comparative Pharmacokinetic , Pharmacodynamic Study , Reference Tocilizumab , Intravenous Route , Normal Healthy Male Volunteer , Global Head , Sustainability Report , Annual Report , Dr Reddys Laboratories Limited Stock Exchange , News , Information , Press Release , Tocilizumab , Us , N , Important , Agent , Ased , The , Treatment , F , Adult , Patients , Ith , Moderate , O , Evere , Ctive , Rheumatoid , Arthritis , Who , Wave , Sad , Inadequate , Response , One , Or 500124 Ine089a01023 ,